Invention Grant
- Patent Title: Multiple specificity binders of CXC chemokines
-
Application No.: US16638992Application Date: 2018-08-17
-
Publication No.: US11485781B2Publication Date: 2022-11-01
- Inventor: Alessandro Angelini , Karl Dane Wittrup , Andrew David Luster
- Applicant: Massachusetts Institute of Technology , The General Hospital Corporation
- Applicant Address: US MA Cambridge; US MA Boston
- Assignee: Massachusetts Institute of Technology,The General Hospital Corporation
- Current Assignee: Massachusetts Institute of Technology,The General Hospital Corporation
- Current Assignee Address: US MA Cambridge; US MA Boston
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- International Application: PCT/US2018/046894 WO 20180817
- International Announcement: WO2019/036605 WO 20190221
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/24 ; A61P19/02 ; C07K14/765 ; A61K39/00

Abstract:
The present disclosure provides for fusion proteins comprising multipsecific variable regions that bind more than one ELR+ CXC chemokine.
Public/Granted literature
- US20210246199A1 MULTIPLE SPECIFICITY BINDERS OF CXC CHEMOKINES AND USES THEREOF Public/Granted day:2021-08-12
Information query